Expert Q&A Presentations

CIDP


Presentations


Speakers

  • Todd Levine, MD

    Todd Levine, MD

    Todd Levine, MD

    Medical Director

    Todd Dylan Levine, MD, is the founder and director of the Phoenix Neurological ALS clinic in Phoenix, Arizona, the medical director of HonorHealth Neurology, and an adjunct professor of neurology at Kansas University. Dr Levine conducts extensive research in diseases of the nerve and muscle. He has published his findings in numerous peer-reviewed journals and lectures both nationally and internationally on these disorders. He is one of the founders of Corinthian Reference Labs and a leader in the field of using skin biopsies for diagnosing small fiber neuropathy. He received his medical degree from Duke University in Durham, North Carolina, and completed a residency in neurology and a fellowship in neuromuscular disease at Washington University School of Medicine in St. Louis, Missouri.
  • Roy L. Freeman, MD

    Roy L. Freeman, MD

    Roy L. Freeman, MD

    Professor of Neurology

    Roy Freeman, MD, is a professor of neurology at Harvard Medical School and director of the Center for Autonomic and Peripheral Nerve Disorders in the Department of Neurology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr Freeman’s research encompasses the neurological complications of diabetes and other peripheral neuropathies, neuropathic pain, the autonomic complications of Parkinson’s disease and multiple system atrophy, biomarkers in neurodegenerative diseases, and the diagnosis and treatment of autonomic and peripheral nervous system disorders. He is the principal investigator on National Institutes of Health-funded studies on the neurological complications of diabetes and biomarker development in alpha-synucleinopathies.
  • Jeffrey Allen, MD

    Jeffrey Allen, MD

    Jeffrey Allen, MD

    Associate Professor, Department of Neurology

    Jeffrey Allen, MD, is assistant professor in the Department of Neurology at the University of Minnesota, Minneapolis and adjunct faculty at Northwestern University in Chicago, Illinois. His primary clinical and academic interests are inflammatory neuropathies, including Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). Dr Allen uses various studies to improve techniques currently used to diagnose inflammatory neuropathy and to identify new and improved treatment methods, including investigating new medications and improving how standard medications are utilized. He is a member of the GBS/CIDP Foundation International Global Medical Advisory Board and on the board of the Inflammatory Neuropathy Consortium (INC).